SBT-77-7101
A novel regulatory T cell-based therapy for patients with rheumatoid arthritis.
An autologous (using the patient’s own cells) Treg cell therapy to target proteins in the inflamed joints of RA patients, with the aim to dampen inflammation and restore balance to the immune system.